Koyfin Home > Directory > Health Care > Amgen Inc > Cash from Financing Activities

Amgen Inc Cash from Financing Activities Chart (AMGN)

Amgen Inc annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Amgen Inc Cash from Financing Activities for the quarter ending September 09, 2020 was $-1,798m a -7.29% increase of 131m year over year
  • Amgen Inc Cash from Financing Activities for the last 12 months ending September 09, 2020 was $-3,206m a -391.80% increase of 12,561m year over year
  • Amgen Inc Annual Cash from Financing Activities for 2019 was $-15,767m a -42.64% increase of 6,723m from 2018
  • Amgen Inc Annual Cash from Financing Activities for 2018 was $-22,490m a 70.68% decrease of -15,896m from 2017
  • Amgen Inc Annual Cash from Financing Activities for 2017 was $-6,594m a 60.59% decrease of -3,995m from 2016
Other Cash Flow Metrics:
  • Amgen Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $3,194m a 14.62% increase of 467m year over year
  • Amgen Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $3,068m a 48.86% increase of 1,499m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN Cash from Financing Activities Data

09/2020$-1,798m
06/2020$775m
03/2020$-254m
12/2019$-1,929m
09/2019$-2,859m
06/2019$-5,992m
03/2019$-4,987m
12/2018$-3,568m
09/2018$-2,580m
06/2018$-4,650m

Annual AMGN Cash from Financing Activities Data

2019$-15,767m
2018$-22,490m
2017$-6,594m
2016$-2,599m
2015$-3,771m
2014$-3,274m
2013$2,726m
2012$419m
2011$-674m
2010$-1,232m